| Product Code: ETC8853934 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Uterine fibroid embolization (UFE) devices are seeing gradual acceptance as a minimally invasive alternative to surgery. The procedure is typically performed in select urban hospitals with interventional radiology departments, and its adoption is supported by a growing emphasis on preserving fertility.
Uterine artery embolization (UAE) devices are being increasingly adopted in private and tertiary hospitals as a fertility-sparing alternative to hysterectomy. Improved access to embolic spheres and interventional radiology expertise is supporting market expansion.
Uterine fibroid embolization (UFE) devices are challenged by poor awareness among patients and limited availability of interventional radiologists. Many healthcare facilities lack the infrastructure for image-guided procedures. Additionally, procedural reimbursement policies are either absent or unclear, discouraging investment.
Uterine artery embolization is increasingly adopted as a minimally invasive treatment. Investors can work with interventional radiologists and hospitals to introduce embolization devices and support training programs. Creating awareness campaigns can help increase procedure volumes and equipment demand.
Devices for uterine fibroid embolization are regulated by the Food and Drug Administration (FDA) as Class II medical devices. Hospitals and clinics must obtain DOH accreditation to perform the procedure, and PhilHealth includes embolization coverage under womens health benefits. Procurement by public institutions follows government tenders with quality assurance protocols to ensure patient safety.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Uterine Fibroid Embolization Device Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Uterine Fibroid Embolization Device Market - Industry Life Cycle |
3.4 Philippines Uterine Fibroid Embolization Device Market - Porter's Five Forces |
3.5 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Uterine Fibroid Embolization Device Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of uterine fibroids in the Philippines |
4.2.2 Growing awareness about minimally invasive treatment options |
4.2.3 Technological advancements in uterine fibroid embolization devices |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals for performing uterine fibroid embolization procedures |
4.3.2 High cost associated with uterine fibroid embolization treatment |
4.3.3 Stringent regulatory requirements for medical devices in the Philippines |
5 Philippines Uterine Fibroid Embolization Device Market Trends |
6 Philippines Uterine Fibroid Embolization Device Market, By Types |
6.1 Philippines Uterine Fibroid Embolization Device Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Gelatin Sponge, 2021- 2031F |
6.1.4 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Polyvinyl Alcohol ( PVA ) Particles, 2021- 2031F |
6.1.5 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Trisacryl Gelatin Microspheres ( TAGM ), 2021- 2031F |
6.1.6 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Polymethyl Methacrylate ( PMMA ) Microspheres, 2021- 2031F |
6.2 Philippines Uterine Fibroid Embolization Device Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Ambulatory Surgery Center, 2021- 2031F |
6.2.4 Philippines Uterine Fibroid Embolization Device Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Uterine Fibroid Embolization Device Market Import-Export Trade Statistics |
7.1 Philippines Uterine Fibroid Embolization Device Market Export to Major Countries |
7.2 Philippines Uterine Fibroid Embolization Device Market Imports from Major Countries |
8 Philippines Uterine Fibroid Embolization Device Market Key Performance Indicators |
8.1 Average waiting time for uterine fibroid embolization procedures |
8.2 Number of hospitals offering uterine fibroid embolization services |
8.3 Patient satisfaction rates with uterine fibroid embolization treatment |
9 Philippines Uterine Fibroid Embolization Device Market - Opportunity Assessment |
9.1 Philippines Uterine Fibroid Embolization Device Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Uterine Fibroid Embolization Device Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Uterine Fibroid Embolization Device Market - Competitive Landscape |
10.1 Philippines Uterine Fibroid Embolization Device Market Revenue Share, By Companies, 2024 |
10.2 Philippines Uterine Fibroid Embolization Device Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here